The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 1998;339(2):139.

Original Article
PreviousPrevious
Volume 338:873-878 March 26, 1998 Number 13
NextNext

Liver Failure and Death after Exposure to Microcystins at a Hemodialysis Center in Brazil
Elise M. Jochimsen, M.D., Wayne W. Carmichael, Ph.D., JiSi An, M.Sc., Denise M. Cardo, M.D., Ph.D., Susan T. Cookson, M.D., Christianne E.M. Holmes, M.D., M. Bernade Antunes, M.D., Djalma A. de Melo Filho, M.D., Tereza M. Lyra, M.D., Victorino Spinelli T. Barreto, M.D., Sandra M.F.O. Azevedo, Ph.D., and William R. Jarvis, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
ABSTRACT

Background Hemodialysis is a common but potentially hazardous procedure. From February 17 to 20, 1996, 116 of 130 patients (89 percent) at a dialysis center (dialysis center A) in Caruaru, Brazil, had visual disturbances, nausea, and vomiting associated with hemodialysis. By March 24, 26 of the patients had died of acute liver failure.

Methods A case patient was defined as any patient undergoing dialysis at dialysis center A or Caruaru's other dialysis center (dialysis center B) during February 1996 who had acute liver failure. To determine the risk factors for and the source of the outbreak, we conducted a cohort study of the 130 patients at dialysis center A and the 47 patients at dialysis center B, reviewed the centers' water supplies, and collected water, patients' serum, and postmortem liver tissue for microcystin assays.

Results One hundred one patients (all at dialysis center A) met the case definition, and 50 died. Affected patients who died were older than those who survived (median age, 47 vs. 35 years; P<0.001). Furthermore, all 17 patients undergoing dialysis on the Tuesday-, Thursday-, and Saturday-night schedule became ill, and 13 of them (76 percent) died. Both centers received water from a nearby reservoir. However, the water supplied to dialysis center B was treated, filtered, and chlorinated, whereas the water supplied to dialysis center A was not. Microcystins produced by cyanobacteria were detected in water from the reservoir and from dialysis center A and in serum and liver tissue of case patients.

Conclusions Water used for hemodialysis can contain toxic materials, and its quality should therefore be carefully monitored.


Source Information

From the Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta (E.M.J., D.M.C., S.T.C., W.R.J.); the Department of Biological Sciences, Wright State University, Dayton, Ohio (W.W.C., J.A.); Secretaria de Saúde de Pernambuco, Recife, Brazil (C.E.M.H., M.B.C.A., D.A.M.F., T.M.L.); Hospital Barão de Lucena, Recife, Brazil (V.S.T.B.); and Núcleo de Pesquisas de Produtos Naturais, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil (S.M.F.O.A.).

Address reprint requests to Dr. Jochimsen at the Hospital Infections Program, Mailstop E-69, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.